These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4771545)

  • 1. [Plaquenil in treatment of systemic lupus erythematosus].
    Wierzchowiecki M
    Pol Tyg Lek; 1973 Nov; 28(47):1866-8. PubMed ID: 4771545
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of hydroxychloroquine therapy on serum levels of immunoregulatory molecules in patients with systemic lupus erythematosus.
    Wallace DJ; Linker-Israeli M; Hyun S; Klinenberg JR; Stecher V
    J Rheumatol; 1994 Feb; 21(2):375-6. PubMed ID: 8182661
    [No Abstract]   [Full Text] [Related]  

  • 3. Pneumocystis carinii pneumonia after discontinuation of hydroxychloroquine in 2 patients with systemic lupus erythematosus.
    Podrebarac TA; Jovaisas A; Karsh J
    J Rheumatol; 1996 Jan; 23(1):199-200. PubMed ID: 8838542
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blepharitis--rare in systemic lupus erythematosus].
    Gyl F; Anna-Adrien C; Oanţă A; Irimie M; Edit FJ
    Oftalmologia; 2008; 52(2):81-3. PubMed ID: 19065920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus.
    Parke A; West B
    J Rheumatol; 1996 Oct; 23(10):1715-8. PubMed ID: 8895146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimalarial drug-induced aquagenic-type pruritus in patients with lupus.
    Jiménez-Alonso J; Tercedor J; Jáimez L; García-Lora E
    Arthritis Rheum; 1998 Apr; 41(4):744-5. PubMed ID: 9550488
    [No Abstract]   [Full Text] [Related]  

  • 7. [Simultaneous incidence of psoriasis and lupus erythematosus and their treatment].
    Ladanyi E; Nagy E
    Z Hautkr; 1977 Jul; 52(14):736-8. PubMed ID: 899109
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chloroquine and hydroxychloroquine dosage in juvenile rheumatoid arthritis].
    Laaksonen AL; Koskiahde V; Juva K
    Duodecim; 1974; 90(2):125-31. PubMed ID: 4848261
    [No Abstract]   [Full Text] [Related]  

  • 9. [Psoriasis and systemic lupus erythematosus: a rare association with specific therapeutic problems].
    Astudillo L; Sailler L; Carreiro M; Dahan S; Ollier S; Arlet P
    Ann Med Interne (Paris); 2003 Feb; 154(1):3-6. PubMed ID: 12746653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroid-sparing strategies in the treatment of retinal vasculitis in systemic lupus erythematosus.
    Neumann R; Foster CS
    Retina; 1995; 15(3):201-12. PubMed ID: 7569347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of long-term treatment of visceral lupus erythematosus with corticosteroids].
    Checińska Z; Galazka A; Szklarz E; Stepień-Dobrowolska M; Miklaszewska M
    Wiad Lek; 1974 Nov; 27(22):1953-8. PubMed ID: 4439907
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug alternatives in therapy of neuropsychiatric systemic lupus erythematosus (NPSLE)].
    Harten P
    Med Klin (Munich); 2003 Jun; 98(6):344; author reply 344-5. PubMed ID: 12877108
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydroxychloroquine in systemic lupus erythematosus.
    Disla E; Brar H; Taranta A
    N Engl J Med; 1991 Oct; 325(14):1046. PubMed ID: 1886629
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dramatic auriculoventricular bloc in a young woman with acute systemic lupus erythematosus. Implantation of a relay pacemaker].
    Slama R; Menkes C; Motte G; Braun S; Forette B; Vanetti A
    Bull Mem Soc Med Hop Paris; 1968 Feb 9-16; 119(3):283-93. PubMed ID: 5703992
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydroxychloroquine-induced cardiotoxicity in a 39-year-old woman with systemic lupus erythematosus and systolic dysfunction.
    Keating RJ; Bhatia S; Amin S; Williams A; Sinak LJ; Edwards WD
    J Am Soc Echocardiogr; 2005 Sep; 18(9):981. PubMed ID: 16153529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lipid, lipoprotein, and apolipoprotein effects of hydroxychloroquine in patients with systemic lupus erythematosus.
    Hodis HN; Quismorio FP; Wickham E; Blankenhorn DH
    J Rheumatol; 1993 Apr; 20(4):661-5. PubMed ID: 8496861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine-induced pigmentation in two patients with systemic lupus erythematosus.
    Reynaert S; Setterfield J; Black MM
    J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):487-8. PubMed ID: 16643169
    [No Abstract]   [Full Text] [Related]  

  • 18. [Disseminated lupus erythematosus. The continued efficacy of hydroxychloroquine scientifically proven by default].
    Carette S
    Union Med Can; 1991; 120(5):360-4. PubMed ID: 1962386
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evolution and prognosis of lupus as a function of several criteria (sex, therapy, diagnosis, clinical form, pregnancy)].
    Geavlete A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981; 33(1):69-74. PubMed ID: 6114537
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of lupus skin involvement with quinacrine and hydroxychloroquine.
    Cavazzana I; Sala R; Bazzani C; Ceribelli A; Zane C; Cattaneo R; Tincani A; Calzavara-Pinton PG; Franceschini F
    Lupus; 2009 Jul; 18(8):735-9. PubMed ID: 19502270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.